Naimish Patel, M.D.

Naimish Patel, M.D.

Chief Medical OfficeratCRISPR Therapeutics AG· In proxies 2024–2025

Pay in FY2025-32% from the year before · CRISPR Therapeutics AG stock +33.2% the same year

Naimish Patel, M.D. was paid $4.3M in FY2025 (Dec), down 32%. CRISPR Therapeutics AG stock rose 33.2% that year.

Pay$100 in the stock at the end of FY23 → $84
Pay is from the Summary Compensation Table of each CRISPR Therapeutics AG proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CRISPR Therapeutics AGPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role -17%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?